{"id":"https://openalex.org/W2017079196","doi":"https://doi.org/10.1089/104454603322126340","title":"Remission Status After Long-Term Sertraline Treatment of Pediatric Obsessive-Compulsive Disorder","display_name":"Remission Status After Long-Term Sertraline Treatment of Pediatric Obsessive-Compulsive Disorder","publication_year":2003,"publication_date":"2003-07-01","ids":{"openalex":"https://openalex.org/W2017079196","doi":"https://doi.org/10.1089/104454603322126340","mag":"2017079196","pmid":"https://pubmed.ncbi.nlm.nih.gov/12880500"},"language":"en","primary_location":{"id":"doi:10.1089/104454603322126340","doi":"https://doi.org/10.1089/104454603322126340","is_oa":false,"landing_page_url":"https://doi.org/10.1089/104454603322126340","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},"volume":null,"type":"article","indexed_in":["crossref","pubmed"],"open_access":{"is_oa":false,"oa_status":"closed","oa_url":null,"any_repository_has_fulltext":false},"authorships":[{"author_position":"first","author":{"id":"https://openalex.org/A5110248081","display_name":"Karen Dineen Wagner","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I55302922","display_name":"The University of Texas Medical Branch at Galveston","ror":"https://ror.org/016tfm930","country_code":"US","type":"education","lineage":["https://openalex.org/I55302922"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Karen Dineen Wagner","raw_affiliation_strings":["Division of Child and Adolescent Psychiatry, University of Texas Medical Branch, Galveston, Texas","Division of Child and Adolescent Psychiatry, University of Texas Medical Branch, Galveston, Texas 77555, USA"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Division of Child and Adolescent Psychiatry, University of Texas Medical Branch, Galveston, Texas","institution_ids":["https://openalex.org/I55302922"]},{"raw_affiliation_string":"Division of Child and Adolescent Psychiatry, University of Texas Medical Branch, Galveston, Texas 77555, USA","institution_ids":["https://openalex.org/I55302922"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5002090056","display_name":"Edwin H. Cook","orcid":"https://orcid.org/0000-0002-5848-5114","observed_orcids":["https://orcid.org/0000-0002-5848-5114"]},"institutions":[{"id":"https://openalex.org/I40347166","display_name":"University of Chicago","ror":"https://ror.org/024mw5h28","country_code":"US","type":"education","lineage":["https://openalex.org/I40347166"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Edwin H. Cook","raw_affiliation_strings":["Departments of Psychiatry and Pediatrics, University of Chicago, Chicago, Illinois"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Departments of Psychiatry and Pediatrics, University of Chicago, Chicago, Illinois","institution_ids":["https://openalex.org/I40347166"]}]},{"author_position":"middle","author":{"id":"https://openalex.org/A5113509801","display_name":"Henry Chung","orcid":"https://orcid.org/0000-0002-9291-9887","observed_orcids":["https://orcid.org/0000-0002-9291-9887"]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Henry Chung","raw_affiliation_strings":["Pfizer Inc., New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., New York, New York","institution_ids":["https://openalex.org/I180857899"]}]},{"author_position":"last","author":{"id":"https://openalex.org/A5043322562","display_name":"Michael Messig","orcid":null,"observed_orcids":[]},"institutions":[{"id":"https://openalex.org/I180857899","display_name":"Pfizer (United States)","ror":"https://ror.org/01xdqrp08","country_code":"US","type":"company","lineage":["https://openalex.org/I180857899"]}],"countries":["US"],"is_corresponding":false,"raw_author_name":"Michael Messig","raw_affiliation_strings":["Pfizer Inc., New York, New York"],"raw_orcid":null,"affiliations":[{"raw_affiliation_string":"Pfizer Inc., New York, New York","institution_ids":["https://openalex.org/I180857899"]}]}],"institutions":[],"countries_distinct_count":1,"institutions_distinct_count":3,"corresponding_author_ids":[],"corresponding_institution_ids":[],"apc_list":null,"apc_paid":null,"fwci":5.3018,"has_fulltext":false,"cited_by_count":63,"citation_normalized_percentile":{"value":0.94614638,"is_in_top_1_percent":false,"is_in_top_10_percent":true},"cited_by_percentile_year":{"min":88,"max":98},"biblio":{"volume":"13","issue":"supplement 1","first_page":"53","last_page":"60"},"is_retracted":false,"is_paratext":false,"is_xpac":false,"primary_topic":{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},"topics":[{"id":"https://openalex.org/T11123","display_name":"Obsessive-Compulsive Spectrum Disorders","score":0.9994999766349792,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T10853","display_name":"Anxiety, Depression, Psychometrics, Treatment, Cognitive Processes","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3205","display_name":"Experimental and Cognitive Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}},{"id":"https://openalex.org/T11132","display_name":"Psychoanalysis and Psychopathology Research","score":0.0,"subfield":{"id":"https://openalex.org/subfields/3203","display_name":"Clinical Psychology"},"field":{"id":"https://openalex.org/fields/32","display_name":"Psychology"},"domain":{"id":"https://openalex.org/domains/2","display_name":"Social Sciences"}}],"keywords":[{"id":"https://openalex.org/keywords/pediatric-obsessive-compulsive-disorder","display_name":"pediatric obsessive-compulsive disorder","score":0.9620000123977661},{"id":"https://openalex.org/keywords/sertraline","display_name":"sertraline","score":0.9980000257492065},{"id":"https://openalex.org/keywords/long-term-treatment","display_name":"long-term treatment","score":0.8180000185966492},{"id":"https://openalex.org/keywords/remission","display_name":"remission","score":0.9700000286102295},{"id":"https://openalex.org/keywords/children-and-adolescents","display_name":"children and adolescents","score":0.6990000009536743},{"id":"https://openalex.org/keywords/children-s-yale-brown-obsessive-compulsive-scale","display_name":"Children's Yale-Brown Obsessive Compulsive Scale","score":0.8529999852180481},{"id":"https://openalex.org/keywords/treatment-response","display_name":"treatment response","score":0.41200000047683716},{"id":"https://openalex.org/keywords/chronicity","display_name":"chronicity","score":0.40700000524520874}],"concepts":[{"id":"https://openalex.org/C2777669559","wikidata":"https://www.wikidata.org/wiki/Q407617","display_name":"Sertraline","level":4,"score":0.8725970983505249},{"id":"https://openalex.org/C3018657049","wikidata":"https://www.wikidata.org/wiki/Q1595418","display_name":"Complete remission","level":3,"score":0.718804121017456},{"id":"https://openalex.org/C3017582312","wikidata":"https://www.wikidata.org/wiki/Q178190","display_name":"Obsessive compulsive","level":2,"score":0.542365312576294},{"id":"https://openalex.org/C27081682","wikidata":"https://www.wikidata.org/wiki/Q269829","display_name":"Placebo","level":3,"score":0.4922434389591217},{"id":"https://openalex.org/C187212893","wikidata":"https://www.wikidata.org/wiki/Q123028","display_name":"Pediatrics","level":1,"score":0.4840640127658844},{"id":"https://openalex.org/C15744967","wikidata":"https://www.wikidata.org/wiki/Q9418","display_name":"Psychology","level":0,"score":0.4740141034126282},{"id":"https://openalex.org/C118552586","wikidata":"https://www.wikidata.org/wiki/Q7867","display_name":"Psychiatry","level":1,"score":0.4561036229133606},{"id":"https://openalex.org/C71924100","wikidata":"https://www.wikidata.org/wiki/Q11190","display_name":"Medicine","level":0,"score":0.3987605571746826},{"id":"https://openalex.org/C126322002","wikidata":"https://www.wikidata.org/wiki/Q11180","display_name":"Internal medicine","level":1,"score":0.33981841802597046},{"id":"https://openalex.org/C558461103","wikidata":"https://www.wikidata.org/wiki/Q154430","display_name":"Anxiety","level":2,"score":0.2927759885787964},{"id":"https://openalex.org/C2776694085","wikidata":"https://www.wikidata.org/wiki/Q974135","display_name":"Chemotherapy","level":2,"score":0.12722790241241455},{"id":"https://openalex.org/C2779177272","wikidata":"https://www.wikidata.org/wiki/Q76560","display_name":"Antidepressant","level":3,"score":0.10398757457733154},{"id":"https://openalex.org/C204787440","wikidata":"https://www.wikidata.org/wiki/Q188504","display_name":"Alternative medicine","level":2,"score":0.0},{"id":"https://openalex.org/C142724271","wikidata":"https://www.wikidata.org/wiki/Q7208","display_name":"Pathology","level":1,"score":0.0}],"mesh":[{"descriptor_ui":"D000293","descriptor_name":"Adolescent","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D000375","descriptor_name":"Aging","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D002648","descriptor_name":"Child","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D005260","descriptor_name":"Female","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D006801","descriptor_name":"Humans","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008134","descriptor_name":"Long-Term Care","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D008297","descriptor_name":"Male","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000188","qualifier_name":"drug therapy","is_major_topic":true},{"descriptor_ui":"D009771","descriptor_name":"Obsessive-Compulsive Disorder","qualifier_ui":"Q000523","qualifier_name":"psychology","is_major_topic":false},{"descriptor_ui":"D011569","descriptor_name":"Psychiatric Status Rating Scales","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D016896","descriptor_name":"Treatment Outcome","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D017367","descriptor_name":"Selective Serotonin Reuptake Inhibitors","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000009","qualifier_name":"adverse effects","is_major_topic":false},{"descriptor_ui":"D020280","descriptor_name":"Sertraline","qualifier_ui":"Q000627","qualifier_name":"therapeutic use","is_major_topic":true},{"descriptor_ui":"D055502","descriptor_name":"Secondary Prevention","qualifier_ui":null,"qualifier_name":null,"is_major_topic":false}],"locations_count":2,"locations":[{"id":"doi:10.1089/104454603322126340","doi":"https://doi.org/10.1089/104454603322126340","is_oa":false,"landing_page_url":"https://doi.org/10.1089/104454603322126340","pdf_url":null,"source":{"id":"https://openalex.org/S198272637","display_name":"Journal of Child and Adolescent Psychopharmacology","issn_l":"1044-5463","issn":["1044-5463","1557-8992"],"is_oa":false,"is_in_doaj":false,"is_core":true,"listed_in":["cwts-core","dongbi-c","doyens","jufo-1","ki-jl-1","medline","norway-1","poland-100","russia-white-list-1","vabb-shw"],"host_organization":"https://openalex.org/P4310320443","host_organization_name":"Mary Ann Liebert, Inc.","host_organization_lineage":["https://openalex.org/P4310320443","https://openalex.org/P4310320017"],"host_organization_lineage_names":["Mary Ann Liebert, Inc.","SAGE Publishing"],"type":"journal"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of Child and Adolescent Psychopharmacology","raw_type":"journal-article"},{"id":"pmid:12880500","doi":null,"is_oa":false,"landing_page_url":"https://pubmed.ncbi.nlm.nih.gov/12880500","pdf_url":null,"source":{"id":"https://openalex.org/S4306525036","display_name":"PubMed","issn_l":null,"issn":null,"is_oa":false,"is_in_doaj":false,"is_core":false,"listed_in":[],"host_organization":"https://openalex.org/I1299303238","host_organization_name":"National Institutes of Health","host_organization_lineage":["https://openalex.org/I1299303238"],"host_organization_lineage_names":[],"type":"repository"},"license":null,"license_id":null,"version":"publishedVersion","is_accepted":true,"is_published":true,"raw_source_name":"Journal of child and adolescent psychopharmacology","raw_type":"Clinical Trial"}],"best_oa_location":null,"sustainable_development_goals":[{"display_name":"Good health and well-being","score":1.0,"id":"https://metadata.un.org/sdg/3"}],"study_designs":[],"awards":[],"funders":[],"has_content":{"pdf":false,"grobid_xml":false},"content_urls":null,"referenced_works_count":17,"referenced_works":["https://openalex.org/W1250937731","https://openalex.org/W1992352843","https://openalex.org/W1994066493","https://openalex.org/W2006536456","https://openalex.org/W2008863502","https://openalex.org/W2046291707","https://openalex.org/W2066656707","https://openalex.org/W2070176743","https://openalex.org/W2081841619","https://openalex.org/W2086747636","https://openalex.org/W2098631889","https://openalex.org/W2106992945","https://openalex.org/W2160214171","https://openalex.org/W2274972696","https://openalex.org/W2473686640","https://openalex.org/W2499089315","https://openalex.org/W3090293687"],"related_works":["https://openalex.org/W2070176743","https://openalex.org/W4389410241","https://openalex.org/W2398392343","https://openalex.org/W7138869162","https://openalex.org/W3197972117","https://openalex.org/W7066802773","https://openalex.org/W2160214171","https://openalex.org/W2026076542","https://openalex.org/W6983242803","https://openalex.org/W2122306597"],"abstract_inverted_index":{"BACKGROUND:":[0],"Despite":[1],"its":[2],"high":[3],"chronicity,":[4],"few":[5],"studies":[6],"have":[7],"evaluated":[8],"the":[9,22,191,227,233],"effectiveness":[10],"of":[11,21,62,100,113,126,149,158,166,193,213,229],"long-term":[12],"treatment":[13,192],"for":[14,38,84],"pediatric":[15],"obsessive-compulsive":[16],"disorder":[17],"(OCD).":[18],"The":[19],"goal":[20],"current":[23],"analysis":[24],"is":[25,188,217],"to":[26,179,203,219],"evaluate":[27],"remission":[28,88,106,144,153,183,204,231],"among":[29],"children":[30],"and":[31,49,59,104,132,151,195,205,222,240],"adolescents":[32,50],"with":[33,36,57,160,198],"OCD":[34,162],"treated":[35],"sertraline":[37,76,81],"12":[39],"months.":[40],"METHODS:":[41],"Children":[42,175],"(6-12":[43],"years":[44,52],"old,":[45,53],"n":[46,54],"=":[47,55],"72)":[48],"(13-18":[51],"65)":[56],"Diagnostic":[58],"Statistical":[60],"Manual":[61],"Mental":[63],"Disorders":[64],"(third":[65],"edition,":[66],"revised)":[67],"OCD,":[68,197],"who":[69],"had":[70],"completed":[71],"a":[72,92,110,129,137,181,210],"12-week,":[73],"double-blind,":[74],"placebo-controlled":[75],"study,":[77],"were":[78,176],"administered":[79],"open-label":[80],"50-200":[82],"mg":[83],"52":[85],"weeks.":[86],"Full":[87],"was":[89,107,145],"defined":[90,108],"by":[91,147,154],"Children's":[93],"Yale-Brown":[94],"Obsessive":[95],"Compulsive":[96],"Scale":[97],"(CY-BOCS)":[98],"score":[99,112],"8":[101],"or":[102,115,168,172],"less,":[103],"partial":[105,138,152,173],"as":[109],"CY-BOCS":[111],"15":[114],"less.":[116],"RESULTS:":[117],"Using":[118],"an":[119,133],"last":[120],"observation":[121],"carried":[122],"forward":[123],"analysis,":[124],"47%":[125],"patients":[127,150,159,235],"achieved":[128,136,146,170],"full":[130,143,171,182,230],"remission,":[131],"additional":[134],"25%":[135],"remission.":[139,174],"Among":[140],"study":[141],"completers,":[142],"55%":[148],"31%.":[155],"Two":[156],"thirds":[157],"severe":[161],"at":[163],"baseline":[164],"(CY-BOCS":[165],"26":[167],"greater)":[169],"more":[177],"likely":[178],"achieve":[180],"than":[184],"adolescents.":[185],"CONCLUSION:":[186],"Sertraline":[187],"effective":[189],"in":[190,209,232],"childhood":[194],"adolescent":[196],"initial":[199],"acute":[200],"response":[201],"converting":[202],"improved":[206],"functional":[207],"status":[208],"substantial":[211],"proportion":[212],"patients.":[214],"More":[215],"research":[216],"needed":[218],"develop":[220],"pharmacologic":[221],"psychotherapeutic":[223],"strategies":[224],"that":[225],"facilitate":[226],"achievement":[228],"remaining":[234],"suffering":[236],"from":[237],"this":[238],"chronic":[239],"disabling":[241],"illness.":[242]},"counts_by_year":[{"year":2026,"cited_by_count":1},{"year":2025,"cited_by_count":1},{"year":2024,"cited_by_count":3},{"year":2022,"cited_by_count":1},{"year":2021,"cited_by_count":1},{"year":2020,"cited_by_count":1},{"year":2019,"cited_by_count":1},{"year":2018,"cited_by_count":1},{"year":2017,"cited_by_count":2},{"year":2016,"cited_by_count":3},{"year":2015,"cited_by_count":5},{"year":2014,"cited_by_count":5},{"year":2012,"cited_by_count":2}],"updated_date":"2026-10-31T12:09:11.096373","created_date":"2016-06-24T00:00:00"}